Library > White Papers > Medicines for Europe



After several months of crisis, Medicines for Europe lays out some of the key lessons learned from COVID-19 for the future of pharmaceutical policy in Europe. The COVID-19 outbreak in Europe has catalysed some long-standing issues in the functioning of pharmaceutical policy,…

We use cookies to ensure that we give you the best experience on our site. For more info click here